Xiaofeng Wu

2.3k total citations
87 papers, 1.5k citations indexed

About

Xiaofeng Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiaofeng Wu has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 16 papers in Cancer Research and 13 papers in Immunology. Recurrent topics in Xiaofeng Wu's work include Extracellular vesicles in disease (15 papers), MicroRNA in disease regulation (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Xiaofeng Wu is often cited by papers focused on Extracellular vesicles in disease (15 papers), MicroRNA in disease regulation (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). Xiaofeng Wu collaborates with scholars based in China, United States and Singapore. Xiaofeng Wu's co-authors include W. Andy Tao, Anton Iliuk, Lawrence Lum, Jianwei Wang, Xinghua Jiang, Li Li, Yan Tan, Ying Zhang, James Kim and Rubina Tuladhar and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaofeng Wu

79 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Wu China 21 1.0k 238 181 156 133 87 1.5k
Shan Lin United States 25 1.2k 1.1× 209 0.9× 183 1.0× 109 0.7× 124 0.9× 55 1.7k
Wenjian Ma China 25 988 1.0× 341 1.4× 220 1.2× 131 0.8× 106 0.8× 80 1.6k
Lei Xue China 25 1.0k 1.0× 337 1.4× 247 1.4× 189 1.2× 111 0.8× 74 1.7k
Carolyn A. Staton United Kingdom 20 982 1.0× 320 1.3× 354 2.0× 120 0.8× 183 1.4× 26 1.7k
Takashi Ohama Japan 22 687 0.7× 130 0.5× 284 1.6× 122 0.8× 78 0.6× 54 1.2k
Lingling Liu China 22 645 0.6× 238 1.0× 267 1.5× 119 0.8× 93 0.7× 83 1.3k
Jikui Shen United States 33 1.7k 1.7× 293 1.2× 127 0.7× 207 1.3× 68 0.5× 59 2.7k
Shuanglin Xiang China 25 1.1k 1.1× 519 2.2× 202 1.1× 191 1.2× 87 0.7× 73 1.7k
André Luiz Mencalha Brazil 22 859 0.8× 315 1.3× 375 2.1× 121 0.8× 96 0.7× 107 1.8k
Hongyan Liang China 20 749 0.7× 324 1.4× 205 1.1× 140 0.9× 65 0.5× 49 1.3k

Countries citing papers authored by Xiaofeng Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Wu more than expected).

Fields of papers citing papers by Xiaofeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Wu. The network helps show where Xiaofeng Wu may publish in the future.

Co-authorship network of co-authors of Xiaofeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Wu. A scholar is included among the top collaborators of Xiaofeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Wu. Xiaofeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaofeng, et al.. (2025). AI-assisted SERS imaging method for label-free and rapid discrimination of clinical lymphoma. Journal of Nanobiotechnology. 23(1). 295–295.
2.
Liu, Chang, Xiaofeng Wu, Fan Huang, et al.. (2024). Efficacy of acupuncture in ameliorating anxiety in Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis. Frontiers in Aging Neuroscience. 16. 1462851–1462851. 2 indexed citations
3.
He, Yuqin, et al.. (2024). ZO-1 and IL-1RAP Phosphorylation: Potential Role in Mediated Brain-Gut Axis Dysregulation in Irritable Bowel Syndrome-like Stressed Mice. International Journal of Medical Sciences. 21(9). 1738–1755. 1 indexed citations
4.
Li, Siwei, Shuibin Wang, Lu Zhang, et al.. (2024). METTL3 methylated KIF15 promotes nasopharyngeal carcinoma progression and radiation resistance by blocking ATG7-mediated autophagy through the activation of STAT3 pathway. Translational Oncology. 51. 102161–102161. 1 indexed citations
5.
Hu, Xueting, Xiaofeng Wu, Jinyi Xu, & Xiang Xu. (2024). Lactate-mediated lactylation in human health and diseases: Progress and remaining challenges. Journal of Advanced Research. 75. 229–248. 14 indexed citations
6.
Wu, Xiaofeng, Yuxin Zhuang, Li Li, et al.. (2024). Monitoring drug metabolic pathways through extracellular vesicles in mouse plasma. PNAS Nexus. 3(2). pgae023–pgae023. 2 indexed citations
7.
8.
Chu, Binbin, Zhiming Chen, Xiaofeng Wu, et al.. (2023). Fluorescence, ultrasonic and photoacoustic imaging for analysis and diagnosis of diseases. Chemical Communications. 59(17). 2399–2412. 32 indexed citations
9.
Shen, Liuhong, et al.. (2023). Exploration of the immuno-adjuvant effect and mechanism of Anemoside B4 through network pharmacology and experiment verification. Phytomedicine. 124. 155302–155302. 7 indexed citations
10.
Liu, Kaige, et al.. (2023). Exploration of the Core Pathways and Potential Targets of Luteolin Treatment on Late-Onset Depression Based on Cerebrospinal Fluid Proteomics. International Journal of Molecular Sciences. 24(4). 3485–3485. 11 indexed citations
11.
Hong, Cheng, et al.. (2023). Percutaneous endovascular biopsy for the diagnosis of pulmonary artery masses: A preliminary study of single‐center. Pulmonary Circulation. 13(2). e12234–e12234. 3 indexed citations
12.
Shen, Liuhong, et al.. (2023). Potential Immunoregulatory Mechanism of Plant Saponins: A Review. Molecules. 29(1). 113–113. 23 indexed citations
13.
Wu, Xiaofeng, et al.. (2023). Mass spectrometry-based phosphoproteomics in clinical applications. TrAC Trends in Analytical Chemistry. 163. 117066–117066. 6 indexed citations
14.
Zhou, Zhiyuan, Xiaofeng Wu, Xiangyong Li, et al.. (2022). Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivo. Cancer Biology & Therapy. 23(1). 1–13. 7 indexed citations
15.
Wu, Xiaofeng & W. Andy Tao. (2022). Uncovering ubiquitous protein lactylation. Nature Methods. 19(7). 793–794. 16 indexed citations
16.
Tuladhar, Rubina, Yunku Yeu, John T. Piazza, et al.. (2019). CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation. Nature Communications. 10(1). 147 indexed citations
17.
Qian, Xin, Xiaofeng Wu, & Xianjun Liu. (2016). Pulmonary alveolar microlithiasis with finger clubbing: A case report and literature review. Experimental and Therapeutic Medicine. 11(4). 1381–1384. 4 indexed citations
18.
Weng, Xun, Yan Tan, Xiaofeng Wu, et al.. (2015). N-methyl-D-aspartic acid receptor 1 (NMDAR1) aggravates secondary inflammatory damage induced by hemin-NLRP3 pathway after intracerebral hemorrhage. Chinese Journal of Traumatology. 18(5). 254–258. 18 indexed citations
19.
Fan, Chih-Wei, Baozhi Chen, Irene Franco, et al.. (2014). The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation. Chemistry & Biology. 21(12). 1680–1689. 20 indexed citations
20.
Novotny‐Diermayr, Veronica, Kanda Sangthongpitag, Xiaofeng Wu, et al.. (2010). SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer. Molecular Cancer Therapeutics. 9(3). 642–652. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shan Lin Breakdown of academic impact, for papers by Wenjian Ma Breakdown of academic impact, for papers by Lei Xue Breakdown of academic impact, for papers by Carolyn A. Staton Breakdown of academic impact, for papers by Takashi Ohama Breakdown of academic impact, for papers by Lingling Liu Breakdown of academic impact, for papers by Jikui Shen Breakdown of academic impact, for papers by Shuanglin Xiang Breakdown of academic impact, for papers by André Luiz Mencalha Breakdown of academic impact, for papers by Hongyan Liang
Rankless by CCL
2026